Sartorius Stedim Biotech (OTCMKTS:SDMHF) Shares Up 4.9% – What’s Next?

Shares of Sartorius Stedim Biotech S.A. (OTCMKTS:SDMHF – Get Free Report) rose 4.9% during mid-day trading on Friday . The company traded as high as $210.80 and last traded at $210.80. 100 shares were traded during mid-day trading, a decline of 95% from the average session volume of 2,180 shares. The stock had previously closed at $201.00.

Sartorius Stedim Biotech Stock Performance

The stock has a 50-day moving average of $198.25 and a 200 day moving average of $210.62.

Sartorius Stedim Biotech Company Profile

(Get Free Report)

Sartorius Stedim Biotech SA (OTCMKTS: SDMHF) is a global provider of bioprocessing equipment and services for the biopharmaceutical industry. The company develops and manufactures technologies that support the development and production of vaccines, monoclonal antibodies, therapeutic proteins and cell‐ and gene‐based therapies. Its solutions address both upstream processes—such as cell cultivation and fermentation—and downstream processes, including filtration, centrifugation and chromatography.

Key product offerings include single‐use bioreactors and mixers, modular filtration assemblies, prepacked chromatography columns, and a wide range of cell culture media and buffer systems.

Read More

• Five stocks we like better than Sartorius Stedim Biotech
• AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target
• Micron’s $250 Billion Bet Could Reshape the AI Memory Race
• Rocket Lab’s Stock Drop Comes With a Bullish Twist
• Amazon’s New Debt Deal Puts Its AI Spending Story on Trial